ACADEMIC AND INDUSTRY PERSPECTIVES ON PHARMACOGENOMICS: DRUG OPTIMIZATION

被引：0
|
作者：
Shuldiner, Alan
机构：
来源：
DRUG METABOLISM AND PHARMACOKINETICS | 2019年 / 34卷 / 01期
关键词：
D O I：
10.1016/j.dmpk.2018.09.030
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
S8
引用
收藏
页码：S6 / S6
页数：1
相关论文
共 50 条
  • [31] Dose Optimization in Oncology Drug Development: The Emerging Role of Pharmacogenomics, Pharmacokinetics, and Pharmacodynamics
    Papachristos, Apostolos
    Patel, Jai
    Vasileiou, Maria
    Patrinos, George P.
    CANCERS, 2023, 15 (12)
  • [32] Quality by design (QbD) approach of pharmacogenomics in drug designing and formulation development for optimization of drug delivery systems
    Gupta, Sumeet
    Jhawat, Vikas
    JOURNAL OF CONTROLLED RELEASE, 2017, 245 : 15 - 26
  • [33] Perspectives and challenges of clinical pharmacogenomics in cancer
    Pusztai, L
    PHARMACOGENOMICS, 2004, 5 (05) : 451 - 454
  • [34] Pharmacogenomics of adverse drug reactions
    Daly, Ann K.
    GENOME MEDICINE, 2013, 5
  • [35] Integrating pharmacogenomics into drug development
    Ferentz, AE
    PHARMACOGENOMICS, 2002, 3 (04) : 453 - 467
  • [36] Pharmacogenomics and variation in drug therapy
    Wong, SHY
    2005 EMERGING INFORMATION TECHNOLOGY CONFERENCE (EITC), 2005, : 52 - 54
  • [37] Pharmacogenomics - ABCs of drug resistance
    Kirkpatrick, P
    NATURE REVIEWS CANCER, 2004, 4 (10) : 755 - 755
  • [38] Pharmacogenomics and the future of drug therapy
    Hines, Ronald N.
    McCarver, D. Gall
    PEDIATRIC CLINICS OF NORTH AMERICA, 2006, 53 (04) : 591 - +
  • [39] Pharmacogenomics of antidepressant drug responses
    McHugh, P
    Rogers, G
    Allington, M
    Cameron, V
    Edgar, P
    Begg, E
    Joyce, P
    Kennedy, M
    AMERICAN JOURNAL OF MEDICAL GENETICS, 2002, 114 (07): : 881 - 881
  • [40] Pharmacogenomics - ABCs of drug resistance
    Kirkpatrick, P
    NATURE REVIEWS DRUG DISCOVERY, 2004, 3 (10) : 828 - 829
12345